These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16162005)

  • 1. Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
    Mattson RJ; Catt JD; Denhart DJ; Deskus JA; Ditta JL; Higgins MA; Marcin LR; Sloan CP; Beno BR; Gao Q; Cunningham MA; Mattson GK; Molski TF; Taber MT; Lodge NJ
    J Med Chem; 2005 Sep; 48(19):6023-34. PubMed ID: 16162005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    King HD; Meng Z; Deskus JA; Sloan CP; Gao Q; Beno BR; Kozlowski ES; Lapaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    J Med Chem; 2010 Nov; 53(21):7564-72. PubMed ID: 20949929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
    Deskus JA; Epperson JR; Sloan CP; Cipollina JA; Dextraze P; Qian-Cutrone J; Gao Q; Ma B; Beno BR; Mattson GK; Molski TF; Krause RG; Taber MT; Lodge NJ; Mattson RJ
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3099-104. PubMed ID: 17391962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.
    Dalton King H; Denhart DJ; Deskus JA; Ditta JL; Epperson JR; Higgins MA; Kung JE; Marcin LR; Sloan CP; Mattson GK; Molski TF; Krause RG; Bertekap RL; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5647-51. PubMed ID: 17766113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
    Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.
    Vangveravong S; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1998 Dec; 41(25):4995-5001. PubMed ID: 9836617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.
    Tamiya J; Dyck B; Zhang M; Phan K; Fleck BA; Aparicio A; Jovic F; Tran JA; Vickers T; Grey J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3328-32. PubMed ID: 18445525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.
    Gerasimov M; Marona-Lewicka D; Kurrasch-Orbaugh DM; Qandil AM; Nichols DE
    J Med Chem; 1999 Oct; 42(20):4257-63. PubMed ID: 10514296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).
    Schmitz WD; Denhart DJ; Brenner AB; Ditta JL; Mattson RJ; Mattson GK; Molski TF; Macor JE
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1619-21. PubMed ID: 15745809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands.
    Raoul M; Patigny D; Fabis F; Dauphin F; Rault S; Sapi J; Laronze JY
    J Enzyme Inhib Med Chem; 2006 Jun; 21(3):251-60. PubMed ID: 16918072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New indole derivatives as potent and selective serotonin uptake inhibitors.
    Malleron JL; Guérémy C; Mignani S; Peyronel JF; Truchon A; Blanchard JC; Doble A; Laduron P; Piot O; Zundel JL
    J Med Chem; 1993 Apr; 36(9):1194-202. PubMed ID: 8487257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of conformationally restricted analogues of milnacipran: (1S, 2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N,N- diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker.
    Shuto S; Ono S; Imoto H; Yoshii K; Matsuda A
    J Med Chem; 1998 Aug; 41(18):3507-14. PubMed ID: 9719604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.